Heme is essential to the function of nearly all cells and organisms, serving chiefly as a prosthetic group for oxygen-carrying proteins and enzymes involved in oxidation/reduction and electron transport reactions. Earlier work focused on in-depth studies on the regulation of, and inter- relationships between, the rate-controlling enzymes of hepatic heme synthesis (ALA synthase) and breakdown (heme oxygenase [HO])./ These studies helped to establish a central role of HO in physiologic heme breakdown and in regulation of activity of ALA synthase and the processes of hepatic porphyrin and heme metabolism. Excess heme may be toxic to cells, and the products of the HO reaction have physiologic roles, functioning as anti-oxidants (biliverdin, bilirubin) or as a neurotransmitter (carbon monoxide). Although two forms of HO have been identified, only form 1 (HO-1) is inducible by heme, certain other metalloporphyrins, and transition metals such as cadmium and cobalt. Metallothionein is another cellular protein involved in cellular defense against toxicity due to metals or other diverse stressful perturbations, and expression of the gene for metallothionein is also increased by these compounds. In previous work from this laboratory, HO-1 was purified from chick liver, and its cDNA was cloned and characterized. The regulation of expression f HO-1 has also been elucidated. The long term goal of this research program is to understand the regulation of hepatic porphyrin and heme metabolism and inter-relationships of this metabolism with cellular hemoproteins. To achieve this goal, the prior accomplishments will serve as the foundation for the achievement of the following specific aims; (1) Complete the sequencing and characterization of the gene for chick HO-1; (2) Carry out functional analysis of the 5'-flanking region of the chick HO-1 gene with the aid of transient and stable transfections of cultured cells using suitable reporter gene constructs; (3) Elucidate the molecular mechanism (s) whereby heme increases transcription of the HO-1 gene, focusing on causes for the transience of this induction and for the rapid development of refractoriness to induction; and (40 Compare the processes and mechanisms of induction of HO-1 and metallothionein mRNA's by heme with those produced by other inducers, particularly cadmium and cobalt and non- heme metalloporphyrins such as manganese- or tin-protoporphyrin. A major working hypothesis is that heme (and perhaps other metalloporphyrins) binds to protein(s0 that then interact selectively and specifically with key regulatory elements that control transcription and/or post-transcriptional activities of HO-1 mRNA. Because of the importance of heme metabolism and hemoproteins in the liver, the results of the proposed studies will provide fundamental new insights into normal biochemistry, molecular biology, and physiology and into key metabolic alterations that occur in disorders of heme metabolism, including the porphyrias, tyrosinemia, lead poisoning, and hyperbilirubinemia. The results will also provide new insights into the effects of transition metals or non-heme metalloporphyrin on normal hepatocytes. The latter are inhibitors of HO that, with heme, are finding increasingly important roles in medical therapeutics. Thus, greater understanding of factors that regulate levels of HO-1 and metallothionein are of broad importance in biology, medicine, pharmacology, and toxicology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK038825-14
Application #
2684168
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1987-01-01
Project End
1999-03-31
Budget Start
1998-07-01
Budget End
1999-03-31
Support Year
14
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Bonkovsky, Herbert L; Hou, Weihong; Steuerwald, Nury et al. (2013) Heme status affects human hepatic messenger RNA and microRNA expression. World J Gastroenterol 19:1593-601
Larion, Sebastian; Caballes, Frederick R; Hwang, Sun-Il et al. (2013) Circadian rhythms in acute intermittent porphyria--a pilot study. Eur J Clin Invest 43:727-39
Maddukuri, Vinaya C; Russo, Mark W; Ahrens, William A et al. (2013) Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient. Dig Dis Sci 58:2413-6
Bonkovsky, Herbert L; Guo, Jun-Tao; Hou, Weihong et al. (2013) Porphyrin and heme metabolism and the porphyrias. Compr Physiol 3:365-401
Hou, Weihong; Tian, Qing; Steuerwald, Nury M et al. (2012) The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes. Biochim Biophys Acta 1819:1113-22
Thapar, Manish; Covault, Jonathan; Hesselbrock, Victor et al. (2012) DNA methylation patterns in alcoholics and family controls. World J Gastrointest Oncol 4:138-44
Ryan Caballes, F; Sendi, Hossein; Bonkovsky, Herbert L (2012) Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver Int 32:880-93
Lakner, Ashley M; Bonkovsky, Herbert L; Schrum, Laura W (2011) microRNAs: fad or future of liver disease. World J Gastroenterol 17:2536-42
Li, Ting; Bonkovsky, Herbert L; Guo, Jun-tao (2011) Structural analysis of heme proteins: implications for design and prediction. BMC Struct Biol 11:13
Rakoski, Mina O; Brown, Morton B; Fontana, Robert J et al. (2011) Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 9:902-909.e1

Showing the most recent 10 out of 142 publications